1.R&D of novel regenerative medicinal products
| Cells | Co-development study with | Indication | Remarks |
|---|---|---|---|
|
Adipose tissues derived from MSC+statin nano-particles (NC-301) |
In-house |
Systemic scleroderma Osteoarthritis of the knee |
Exclusively global license agreement Completed PCT application Granted US patent |
|
Pharmaceutical composition for treating skin diseases |
In-house |
External preparation for hair growth External preparation for skin regeneration （For osmetic use) |
Agreement to obtain a Japanese and foreign countries license Completed PCT application |